Skip to main content

Advertisement

Table 5 Proportion of promoter hypermethylation in MGMT, CDKN2A and RASFF1 in oral and pharyngeal cancer tissues

From: Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation

N of subjects (%) N = 61 MGMT CDKN2A RASSF1
35 (57.3) - - -
13 (21.3) + - -
5 (8.2) - + -
2 (3.3) - - +
4 (6.6) + - +
1 (1.6) + + -
0 (0.0) - + +
1 (1.6) + + +
  1. +: methylated
  2. -: unmethylated